Cargando…

The status of naloxone in community pharmacies across Canada

Detalles Bibliográficos
Autores principales:	So, Randy, Al Hamarneh, Yazid, Barnes, Mark, Beazely, Michael A., Boivin, Michael, Laroche, Julie, Patel, Harsit, Sihota, Aaron, Smith, Tim, Tsuyuki, Ross T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research and Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689620/ https://www.ncbi.nlm.nih.gov/pubmed/33282025 http://dx.doi.org/10.1177/1715163520958435

Ejemplares similares

Canadian national consensus guidelines for naloxone prescribing by pharmacists
por: Tsuyuki, Ross T., et al.
Publicado: (2020)

Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes
por: So, Randy, et al.
Publicado: (2021)

What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review
por: Cid, Ashley, et al.
Publicado: (2021)

Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial
por: Cid, Ashley, et al.
Publicado: (2022)

Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another
por: Daskalakis, George, et al.
Publicado: (2021)

R(x)IALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre–post intervention study
por: Al Hamarneh, Yazid N, et al.
Publicado: (2021)

After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study
por: Al Hamarneh, Yazid N, et al.
Publicado: (2015)

Real-world implementation of diabetes management by pharmacists: The R(X)ING Practice Tool
por: Al Hamarneh, Yazid N., et al.
Publicado: (2021)

The effects of heat and freeze-thaw cycling on naloxone stability
por: Lai, Dulcie, et al.
Publicado: (2019)

Pharmacist intervention for glycaemic control in the community (the RxING study)
por: Al Hamarneh, Yazid N, et al.
Publicado: (2013)

The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial
por: Smyth, Penelope, et al.
Publicado: (2022)

Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis
por: Antoniou, Tony, et al.
Publicado: (2021)

Naloxone availability in independent community pharmacies in Georgia, 2019
por: Gilbert, Lauren, et al.
Publicado: (2021)

Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire
por: Bolivar, Derek, et al.
Publicado: (2023)

Evaluating the impact of patient-reported outcome measures on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial
por: Chu, Nathan Y., et al.
Publicado: (2023)

A photovoice study on community pharmacists’ roles and lived experiences during the COVID-19 pandemic
por: Watson, Kaitlyn E., et al.
Publicado: (2023)

Impact of COVID-19 on frontline pharmacists’ roles and services in Canada: The INSPIRE Survey
por: Lee, Dillon H., et al.
Publicado: (2021)

Will converting naloxone to over‐the‐counter status increase pharmacy sales?
por: Murphy, Sean M., et al.
Publicado: (2019)

Pharmacy in medieval Islam and the history of drug addiction.
por: Hamarneh, S
Publicado: (1972)

Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017
por: Guadamuz, Jenny S., et al.
Publicado: (2019)

Public Perceptions of Community Pharmacy-Based Naloxone Services: A National Cross-Sectional Survey
por: Hohmann, Lindsey A., et al.
Publicado: (2022)

Electronic Advisories Increase Naloxone Prescribing Across Health Care Settings
por: Heiman, Erica, et al.
Publicado: (2022)

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone
por: Green, Traci C., et al.
Publicado: (2015)

Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018
por: Guy, Gery P., et al.
Publicado: (2019)

Effectiveness of an Advanced Naloxone Training, Simulation, and Assessment of Second-Year Pharmacy Students
por: Courtney, Jennifer, et al.
Publicado: (2022)

The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study
por: Choremis, Beatrice, et al.
Publicado: (2019)

Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study
por: Teeter, Benjamin S., et al.
Publicado: (2021)

Guidance on take-home naloxone distribution and use by community overdose responders in Canada
por: Ferguson, Max, et al.
Publicado: (2023)

Achieving Influenza Vaccine Uptake Target in Canada via a Pharmacy-Led Telephone Discussion during the 2019–2020 Season
por: Strain, William David, et al.
Publicado: (2021)

Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016
por: Meyerson, B.E., et al.
Publicado: (2018)

Increasing proactive co-dispensing of take-home naloxone with prescription opioids at Ontario community pharmacies
por: Qiu Hua Chen, Autumn
Publicado: (2022)

Naloxone Accessibility Under the State Standing Order Across Mississippi
por: Gravlee, Emily, et al.
Publicado: (2023)

Pharmacy Students’ Perceptions and Stigma Surrounding Naloxone Use in Patients with Opioid Use Disorder: A Mixed Methods Evaluation
por: Cernasev, Alina, et al.
Publicado: (2020)

Refocusing on hypertension control in Canada
por: Leung, Alexander A., et al.
Publicado: (2021)

Cost-effectiveness of pharmacist care for managing hypertension in Canada
por: Marra, Carlo, et al.
Publicado: (2017)

Evaluation of a large-scale health department naloxone distribution program: Per capita naloxone distribution and overdose morality
por: Freiermuth, Caroline E., et al.
Publicado: (2023)

Patterns of drug-related problems and the services provided to optimize drug therapy in the community pharmacy setting
por: Jarab, Anan S., et al.
Publicado: (2023)

Naloxone Audit
por: Venan, Paster
Publicado: (2023)

Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data
por: Moustaqim-Barrette, Amina, et al.
Publicado: (2020)

Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
por: Dadiomov, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gs7ckn84i53t0muqeaqcp9l1m6